| Title : Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay - Yamamoto_2016_Antimicrob.Agents.Chemother_60_6532 |
| Author(s) : Yamamoto M , Matsuyama S , Li X , Takeda M , Kawaguchi Y , Inoue JI , Matsuda Z |
| Ref : Antimicrobial Agents & Chemotherapy , 60 :6532 , 2016 |
| Abstract : Yamamoto_2016_Antimicrob.Agents.Chemother_60_6532 |
| ESTHER : Yamamoto_2016_Antimicrob.Agents.Chemother_60_6532 |
| PubMedSearch : Yamamoto_2016_Antimicrob.Agents.Chemother_60_6532 |
| PubMedID: 27550352 |
Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z (2016)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Antimicrobial Agents & Chemotherapy
60 :6532
Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z (2016)
Antimicrobial Agents & Chemotherapy
60 :6532